- ROUNDTABLE: Pharmacy’s future in sync with technology
- Coalition of healthcare industry stakeholders address best practices regarding controlled substances
- EXPERT BLOG: Provider status for pharmacists — one way or another
- Study from NCPA sheds new light on med synchronization programs
- Walgreens Infusion Services can save $10.8 million in healthcare costs annually
There are several important pieces of legislation that will have an impact on the business of supermarket pharmacy if passed, noted Michael Spira, American Pharmacists Association senior lobbyist, during an FMI education session.
The Senate recently passed legislation on drug compounding, for example. A House version of compounding legislation is expected within the next month, Spira said.
A hydrocodone bill that beefs up requirements and penalties related to dispensing the narcotic pain reliever has been introduced in both the House and Senate. And track-and-trace drafts that would require monitoring pharmaceuticals at the lot and unit levels recently have been introduced in both divisions of Congress, Spira added.